Endogenous Bak inhibitors Mcl-1 and Bcl-x(L): differential impact on TRAIL resistance in Bax-deficient carcinoma

Tumor necrosis factor (α)–related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent that preferentially kills tumor cells with limited cytotoxicity to nonmalignant cells. However, signaling from death receptors requires amplification via the mitochondrial apoptosis pathway (type II)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillissen, Bernhard, Wendt, Jana, Richter, Antje, Richter, Anja, Müer, Annika, Overkamp, Tim, Gebhardt, Nina, Preissner, Robert, Belka, Claus, Dörken, Bernd, Daniel, Peter T.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2010
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845080/
https://www.ncbi.nlm.nih.gov/pubmed/20308427
http://dx.doi.org/10.1083/jcb.200912070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845080/
https://www.ncbi.nlm.nih.gov/pubmed/20308427
http://dx.doi.org/10.1083/jcb.200912070

Ejemplares similares